Clinical research - Press Releases

Date	Title	Company
28-Nov-2023	Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project	Ebenbuild GmbH
27-Nov-2023	POCKET-SIZED DNA SEQUENCERS TRACK MALARIA DRUG RESISTANCE IN GHANA IN NEAR REAL-TIME	Wellcome Sanger Institute and University of Ghana
25-Nov-2023	Biotech firm raises £1.25m for human gut model as alternative to animal testing	Aelius Biotech
24-Nov-2023	Guinea: Progress Made in HIV Care but Major Challenges Remain/ World AIDS DAY 2023	Médecins Sans Frontières/ Doctors Without Borders (MSF)
24-Nov-2023	European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5	European Commission
24-Nov-2023	Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug Administration EP0031/A400, a next generation selective RET inhibitor (SRI), is currently being investigated as a treatment option for patients with RET altered tumours	Ellipses
23-Nov-2023	ASTRAZENECA SECURES NHS ACCESS TO IMFINZI▼(DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN IN ADVANCED BILIARY TRACT CANCER ACROSS ENGLAND AND WALES	Astrazeneca
23-Nov-2023	EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK	Edwards Lifesciences
23-Nov-2023	CellCentric’s inobrodib exhibits a novel mechanism of action with potential to treat a number of haematological malignancies: new data published in Cancer Cell	CellCentric
21-Nov-2023	Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care.	ATHENA
21-Nov-2023	Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing	Immix Biopharma, Inc.
21-Nov-2023	iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference	iTeos
21-Nov-2023	Cherwell welcomes new recruits as pharma environmental monitoring needs grow	Cherwell
21-Nov-2023	UK Medical Devices Regulations: TÜV Rheinland is now a UK Approved Body according to UK MDR	TÜV Rheinland
21-Nov-2023	Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	Myricx Bio
21-Nov-2023	Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM	Vironova BioAnalytics
21-Nov-2023	EDX MEDICAL & THERMO FISHER SCIENTIFIC TO COLLABORATE ON DEVELOPMENT OF INNOVATIVE CANCER TESTS FOR GLOBAL MARKETS	EDX Medical Group plc
21-Nov-2023	Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes	ViCentra B.V.
21-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
21-Nov-2023	European Commission Approves pharmaand GmbH’s Rubraca® (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer	pharmaand GmbH